FDA Alignment to Advance ProstACT Global Phase 3 Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. NKE
2. TSLA
3. SPY
4. MU
5. ABVX
6. NVDA
7. BE
8. SPCX
9. STZ
10. META

Go back to FDA Alignment to Advance ProstACT Global Phase 3 Trial
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.84 +0.31 (2.69%)
Previous Close $11.53    52 Week High $2.18 
Open $11.72    52 Week Low $0.30 
Day High $11.90    P/E N/A 
Day Low $11.70    EPS $-3.32 
Volume 172,395       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.84 +0.31 (2.69%)
Previous Close $11.53    52 Week High $2.18 
Open $11.72    52 Week Low $0.30 
Day High $11.90    P/E N/A 
Day Low $11.70    EPS $-3.32 
Volume 172,395